Validation of the Mayo Clinic Percutaneous Coronary Intervention Risk Prediction Score in Patients With Acute Coronary Syndrome
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.125.043012 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Antonio Landi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiocentro Ticino Institute Ente Ospedaliero Cantonale (EOC) Lugano Switzerland. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Decision Support Techniques, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
A contemporary, comprehensive risk score for the prediction of in‐hospital fatal and nonfatal adverse events after percutaneous coronary intervention has been recently developed, albeit its external validation in patients with acute coronary syndrome is lacking. The objective of this study is to validate the Mayo Clinic integer risk score in a large cohort of patients with acute coronary syndrome undergoing percutaneous coronary intervention from the MATRIX (Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of Angiox) trial.
Methods
The risk score is composed of a common set of 23 clinical and procedural variables (model A) and 18 preprocedural variables (model B). The primary objective was to appraise the receiver‐operator characteristics of both models for in‐hospital mortality, bleeding, contrast‐associated acute kidney injury, and stroke. The impact of risk score categories on 1‐year outcomes was also investigated.
Results
Among the 6724 patients undergoing percutaneous coronary intervention in the MATRIX trial, the receiver‐operator characteristics—area under the curves for in‐hospital mortality, bleeding, contrast‐associated acute kidney injury, and stroke were 0.88 (95% CI, 0.85–0.91), 0.66 (95% CI, 0.63–0.69), 0.70 (95% CI, 0.67–0.72), and 0.65 (95% CI, 0.52–0.78) for model A and 0.88 (95% CI, 0.84–0.92), 0.63 (95% CI, 0.60–0.66), 0.66 (95% CI, 0.63–0.69), and 0.65 (95% CI, 0.52–0.78) for model B, respectively. Mortality (model A), bleeding, and stroke risks were well calibrated, whereas mortality (model B) and contrast‐associated acute kidney injury risk were underestimated. There was a gradual risk increase for 1‐year mortality and bleeding as a function of the risk score tertile using both models.
Conclusions
The risk score identifies patients with acute coronary syndrome at incremental risk of in‐hospital mortality, bleeding, contrast‐associated acute kidney injury, and stroke, representing a valuable tool for mitigation of modifiable risk factors. Registration URL: https://www.clinicaltrials.gov ; Unique Identifier: NCT01433627.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiocentro Ticino Institute Ente Ospedaliero Cantonale (EOC) Lugano Switzerland.
- Faculty of Biomedical Sciences University of Italian Switzerland Lugano Switzerland.
- Department of Cardiovascular and Pulmonary Sciences Università Cattolica del Sacro Cuore Rome Italy.
- Department of Cardiovascular Medicine Mayo Clinic Rochester MN USA.
- Division of Cardiology University of Florida College of Medicine-Jacksonville FL 32209 USA.
- Division of Cardiology Azienda Ospedaliero Universitaria Policlinico "G. Rodolico-San Marco" University of Catania Catania 95123 Italy.
ORCID-Profile: Andrea Zito, Mandeep Singh, Dominick J Angiolillo, Davide Capodanno, Sunil V Rao, Marco Valgimigli
Zitieren
APA
Landi, A., Zito, A., Singh, M., Angiolillo, D. J., Capodanno, D., Frigoli, E., Milzi, A., Rao, S. V., Urban, P., & Valgimigli, M. (2025). Validation of the Mayo Clinic Percutaneous Coronary Intervention Risk Prediction Score in Patients With Acute Coronary Syndrome. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.043012
Vancouver
Landi A, Zito A, Singh M, Angiolillo DJ, Capodanno D, Frigoli E, et al. Validation of the Mayo Clinic Percutaneous Coronary Intervention Risk Prediction Score in Patients With Acute Coronary Syndrome. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.043012
BibTeX
@article{Landi2025,
author = {Landi, Antonio and Zito, Andrea and Singh, Mandeep and Angiolillo, Dominick J and Capodanno, Davide and Frigoli, Enrico and Milzi, Andrea and Rao, Sunil V and Urban, Philip and Valgimigli, Marco},
title = {Validation of the Mayo Clinic Percutaneous Coronary Intervention Risk Prediction Score in Patients With Acute Coronary Syndrome},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.125.043012}
}
EUVIMED